Pages that link to "Q29617084"
Jump to navigation
Jump to search
The following pages link to p53 and metabolism (Q29617084):
Displaying 50 items.
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology (Q21129303) (← links)
- The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase (Q24294745) (← links)
- The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells (Q24297086) (← links)
- Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts (Q24298359) (← links)
- Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1 (Q24298615) (← links)
- Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death (Q24305032) (← links)
- Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species (Q24305112) (← links)
- p53 regulates Period2 expression and the circadian clock (Q24336862) (← links)
- p53 opens the mitochondrial permeability transition pore to trigger necrosis (Q24338796) (← links)
- DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected] (Q24339462) (← links)
- Links between metabolism and cancer (Q24626229) (← links)
- Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor (Q24631421) (← links)
- Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol (Q24654272) (← links)
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy (Q26740191) (← links)
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells (Q26750861) (← links)
- Metabolic communication in tumors: a new layer of immunoregulation for immune evasion (Q26765256) (← links)
- Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism (Q26778362) (← links)
- Cancer metabolism: key players in metabolic reprogramming (Q26827663) (← links)
- The role of mitochondrial bioenergetics and reactive oxygen species in coronary collateral growth (Q26851520) (← links)
- Metabolic modulation of chromatin: implications for DNA repair and genomic integrity (Q26861294) (← links)
- Serine and glycine metabolism in cancer (Q26863700) (← links)
- Tumor suppressor p53 and its gain-of-function mutants in cancer (Q27000754) (← links)
- Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1 (Q27003153) (← links)
- Tumor suppressor p53 and its mutants in cancer metabolism (Q27010683) (← links)
- Cancer cell metabolism: implications for therapeutic targets (Q27013632) (← links)
- Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway (Q27022918) (← links)
- The Warburg effect revisited--lesson from the Sertoli cell (Q27025749) (← links)
- Small molecule compounds targeting the p53 pathway: are we finally making progress? (Q27027835) (← links)
- Aberrant autolysosomal regulation is linked to the induction of embryonic senescence: differential roles of Beclin 1 and p53 in vertebrate Spns1 deficiency (Q27315143) (← links)
- Comparative Analysis of Muscle Transcriptome between Pig Genotypes Identifies Genes and Regulatory Mechanisms Associated to Growth, Fatness and Metabolism (Q27334737) (← links)
- Assessment, origin, and implementation of breath volatile cancer markers (Q27692565) (← links)
- Imaging metabolic heterogeneity in cancer (Q28076500) (← links)
- The role of the p53 tumor suppressor in metabolism and diabetes (Q28079903) (← links)
- IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis (Q28115805) (← links)
- Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer (Q28267156) (← links)
- Regulation of cancer cell metabolism (Q28303890) (← links)
- The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis (Q28388257) (← links)
- The Intercellular Metabolic Interplay between Tumor and Immune Cells (Q28391079) (← links)
- Cell biology. Metabolic control of cell death (Q28397089) (← links)
- Anoikis resistance: an essential prerequisite for tumor metastasis (Q28397372) (← links)
- p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system (Q28478414) (← links)
- Two 4N cell-cycle arrests contribute to cisplatin-resistance (Q28485896) (← links)
- Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage (Q28510160) (← links)
- Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance (Q28535061) (← links)
- Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines (Q28553394) (← links)
- TIGAR is required for efficient intestinal regeneration and tumorigenesis (Q28585472) (← links)
- SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63 (Q28589378) (← links)
- Progress and bottleneck in induced pluripotency (Q28652287) (← links)
- Radiation metabolomics and its potential in biodosimetry (Q28708956) (← links)